Krystal Biotech
Price & Volume
Stats
See moreOpen | $168.29 |
Previous Close | $167.82 |
Day Range | $168.29-$170.71 |
52W Range | $122.80-$207.84 |
Market Cap | $4.8B |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $359.2M |
Revenue Growth (YoY) | 36.6% |
Gross Profit (12 Mos) | $335.3M |
Diluted EPS | $4.92 |
News
See moreYahoo Finance • 14 days ago
Krystal Biotech gets expanded FDA approval for Vyjuvek
Yahoo Finance • 14 days ago
Krystal Biotech Announces FDA Approval of Updated VYJUVEK® Label
Yahoo Finance • last month
Krystal Biotech Announces Update on Development Plans for Oncology Program KB707 and Prioritization of Inhaled KB707 for the Treatment of Non-Small Cell Lung Cancer
Yahoo Finance • 2 months ago
Krystal Biotech price target lowered to $182 from $192 at BofA
About
CEO | Mr. Krish S. Krishnan M.B.A., M.S. |
Address | 2100 Wharton Street, Pittsburgh, PA, United States, 15203 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 275 |
